Cargando…

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales:	Smith, Lindsay D., Minton, Annabel R., Blunt, Matthew D., Karydis, Laura I., Dutton, David A., Rogers-Broadway, Karly-Rai, Dobson, Rachel, Liu, Rena, Norster, Faith, Hogg, Elizabeth, Ashton-Key, Margaret, Strefford, Jonathan C., Jia, Li, Efremov, Dimitar G., Helgason, G. Vignir, Johnson, Peter W. M., Stevenson, Freda K., Forconi, Francesco, Cragg, Mark S., Tumbarello, David A., Packham, Graham, Steele, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995694/ https://www.ncbi.nlm.nih.gov/pubmed/31462734 http://dx.doi.org/10.1038/s41375-019-0557-y

Ejemplares similares

Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL
por: Bryant, Dean, et al.
Publicado: (2023)

B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells
por: Taylor, Joe, et al.
Publicado: (2022)

B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells
por: Minton, Annabel R., et al.
Publicado: (2022)

Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells
por: Wilmore, Sarah, et al.
Publicado: (2021)

Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells
por: Linley, Adam J., et al.
Publicado: (2021)

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
por: Valle-Argos, Beatriz, et al.
Publicado: (2021)

The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought
por: Ianniciello, Angela, et al.
Publicado: (2018)

Folate metabolism: a re-emerging therapeutic target in haematological cancers
por: Zarou, Martha M., et al.
Publicado: (2021)

Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia
por: de Beauchamp, Lucie, et al.
Publicado: (2021)

Amplification efficiency and thermal stability of qPCR instrumentation: Current landscape and future perspectives
por: ROGERS-BROADWAY, KARLY-RAI, et al.
Publicado: (2015)

Unraveling Heterogeneity in the Aging Hematopoietic Stem Cell Compartment: An Insight From Single-cell Approaches
por: Yang, Fei, et al.
Publicado: (2023)

Metabolism in stem cell–driven leukemia: parallels between hematopoiesis and immunity
por: Rattigan, Kevin M., et al.
Publicado: (2023)

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
por: Mitchell, Rebecca, et al.
Publicado: (2017)

Elucidating the role of DEPTOR in Alzheimer’s disease
por: DAVIES, JULIE, et al.
Publicado: (2014)

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
por: Fisher, Jack G., et al.
Publicado: (2021)

PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis
por: Carter, M J, et al.
Publicado: (2017)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Utilizing Stimulated Raman Scattering Microscopy To Study Intracellular Distribution of Label-Free Ponatinib in Live Cells
por: Sepp, Kristel, et al.
Publicado: (2019)

BCR: a new target in resistance mediated by BCR/ABL-315I?
por: Haberbosch, Isabella, et al.
Publicado: (2016)

BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia
por: Parry, Narissa, et al.
Publicado: (2022)

HAX1 deletion impairs BCR internalization and leads to delayed BCR-mediated apoptosis
por: Wolkerstorfer, Susanne, et al.
Publicado: (2016)

Core Fucosylation Regulates the Function of Pre-BCR, BCR and IgG in Humoral Immunity
por: Sun, Yuhan, et al.
Publicado: (2022)

Therapeutic Targets in Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2020)

Editorial: The notch signaling pathway in lymphoid malignancies
por: Fais, Franco, et al.
Publicado: (2023)

The riddle of lymphoma BCR-antigenes
por: Thurner, Lorenz, et al.
Publicado: (2018)

The FcμR Limits Tonic BCR Signaling by Regulating IgM-BCR Expression
por: Nguyen, Trang T. T., et al.
Publicado: (2017)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro
por: ROGERS-BROADWAY, KARLY-RAI, et al.
Publicado: (2016)

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemic stem cells
por: Kuntz, Elodie M., et al.
Publicado: (2017)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Kawakami, Shohei, et al.
Publicado: (2022)

Alternative end-joining in BCR gene rearrangements and translocations: Alternative end-joining in BCR gene rearrangements and translocations
por: Bai, Wanyu, et al.
Publicado: (2022)

Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
por: Foxall, Russell, et al.
Publicado: (2021)

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
por: Efremov, Dimitar G., et al.
Publicado: (2012)

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
por: Efremov, Dimitar G., et al.
Publicado: (2020)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Spinal Cord Injury and Migraine Headache: A Population-Based Study
por: Warner, Freda M., et al.
Publicado: (2015)

Correction: Spinal Cord Injury and Migraine Headache: A Population-Based Study
por: Warner, Freda M., et al.
Publicado: (2015)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins
por: You, Liangshun, et al.
Publicado: (2016)

Expanding the Diversity of Allosteric Bcr-Abl Inhibitors
por: Deng, Xianming, et al.
Publicado: (2010)

An In-House Method for Molecular Monitoring of BCR-ABL
por: Sercan, Hakkı Ogün, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5iji84nvvh027j19evtfoetq68